Literature DB >> 24365218

Surgical therapy of pulmonary aspergillomas: a 30-year North American experience.

Ashok Muniappan1, Luis F Tapias2, Parag Butala2, John C Wain2, Cameron D Wright2, Dean M Donahue2, Henning A Gaissert2, Michael Lanuti2, Douglas J Mathisen2.   

Abstract

BACKGROUND: Pulmonary aspergilloma is resected to control life-threatening complications such as massive hemoptysis. The role of prophylactic resection in asymptomatic patients is unclear.
METHODS: A retrospective review was conducted of 60 patients treated at a tertiary center from 1980 to 2010.
RESULTS: The mean age in 34 (56.7%) men and 26 (43.3%) women was 51 years. Immunosuppression, most commonly from chronic steroid use, was present in 17 (28.3%) patients, and preexisting lung disease was present in 47 (78.3%) patients. Hemoptysis occurred in 33 (55%) patients, whereas 9 (15.0%) patients were asymptomatic. Aspergilloma was simple in 13 (21.7%) patients and complex in 47 (78.3%) patients. Surgical approach was by thoracotomy (n=51 [85.0%]), video-assisted thoracoscopic surgery (n=7 [11.7%]), or a cavernostomy (n=2 [3.3%]). Sublobar resections (n=28 [46.7%]) were most common, followed by lobectomy (n=27 [45%]) and pneumonectomy (n=3 [5%]). Postoperative morbidity occurred in 18 (30%) patients, with prolonged air leak the most frequent complication (n=9 [15%]). Two (3.3%) patients experienced empyema, and 4 (6.7%) patients had bronchopleural fistulas (BPFs). Two patients died within 30 days (3.3%). During a mean follow-up of 54.1±62.2 months, 3 patients had recurrent aspergillomas (5.0%). Actuarial 10-year survival was 62.5% for simple and 68.5% for complex aspergillomas (p=0.858). Comorbid conditions (human immunodeficiency virus [HIV] positivity, malignancy) and male sex were associated with lower survival.
CONCLUSIONS: Selective surgical treatment favoring lesser pulmonary resection results in fungal eradication and control in most patients. Overall survival is similar after surgical management of simple and complex aspergillomas.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  11

Mesh:

Year:  2013        PMID: 24365218     DOI: 10.1016/j.athoracsur.2013.10.050

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Feasibility of surgery for pulmonary aspergilloma: analysis of the operative modes.

Authors:  Kazuyuki Komori; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-03-14

2.  Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection.

Authors:  Geena X Wu; Marine Khojabekyan; Jami Wang; Bernard R Tegtmeier; Margaret R O'Donnell; Jae Y Kim; Frederic W Grannis; Dan J Raz
Journal:  Eur J Cardiothorac Surg       Date:  2015-03-01       Impact factor: 4.191

3.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

4.  The fate of aspergilloma patients after surgical treatment-experience from 22 cases.

Authors:  Katriina Pihlajamaa; Veli-Jukka Anttila; Jari V Räsänen; Juha T Kauppi; Ulla Hodgson
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

5.  Risk factors of severe hemoptysis in patients with fungus ball.

Authors:  Tae Hoon Kim; Hyun Jung Koo; Chae-Man Lim; Sang-Bum Hong; Jin Won Huh; Kyung Wook Jo; Tae Sun Shim; Woo Sung Kim; Younsuck Koh
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

6.  Surgery for localized pulmonary mycotic infections in patients with hematopoietic disorder.

Authors:  Youngkyu Moon; Jae Kil Park; Sook Whan Sung
Journal:  J Cardiothorac Surg       Date:  2015-06-30       Impact factor: 1.637

Review 7.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07

8.  Intervention treatment on massive hemoptysis of pulmonary aspergilloma.

Authors:  Guanghui He; Wenyu Liu; Zhiqiang Gao; Zhi Gao; Hongsheng Gao; Yanjie Wang
Journal:  Exp Ther Med       Date:  2017-03-15       Impact factor: 2.447

9.  Video-assisted thoracoscopic surgery for pulmonary aspergilloma.

Authors:  Arvind Kumar; Belal Bin Asaf; Harsh Vardhan Puri; Vijay C Lingaraju; Shireen Siddiqui; Pulle Mohan Venkatesh; Jayashree Sood
Journal:  Lung India       Date:  2017 Jul-Aug

10.  Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.

Authors:  David W Denning; Iain D Page; Jeremiah Chakaya; Kauser Jabeen; Cecilia M Jude; Muriel Cornet; Ana Alastruey-Izquierdo; Felix Bongomin; Paul Bowyer; Arunaloke Chakrabarti; Sara Gago; John Guto; Bruno Hochhegger; Martin Hoenigl; Muhammad Irfan; Nicholas Irurhe; Koichi Izumikawa; Bruce Kirenga; Veronica Manduku; Samihah Moazam; Rita O Oladele; Malcolm D Richardson; Juan Luis Rodriguez Tudela; Anna Rozaliyani; Helmut J F Salzer; Richard Sawyer; Nasilele F Simukulwa; Alena Skrahina; Charlotte Sriruttan; Findra Setianingrum; Bayu A P Wilopo; Donald C Cole; Haileyesus Getahun
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.